Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Applicant: Bristol Myers Squibb

« Back to Dashboard

Summary for Applicant: Bristol Myers Squibb

Patents:27
Tradenames:70
Ingredients:63
NDAs:83
Drug Master File Entries: (click here to view)75
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
STILBETIN
diethylstilbestrol
TABLET;ORAL004056Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Bristol Myers Squibb
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION)022065Oct 16, 2007RXYesRE41911*PED<disabled><disabled>
Bristol Myers Squibb
BUSPAR
buspirone hydrochloride
TABLET;ORAL018731Sep 29, 1986DISCNNo<disabled><disabled>
Bristol Myers Squibb
SPRYCEL
dasatinib
TABLET;ORAL021986May 30, 2008RXNo7,153,856<disabled><disabled>
Bristol Myers Squibb
SUSTIVA
efavirenz
CAPSULE;ORAL020972Sep 17, 1998RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
This search can help find similar names.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc